Journal of Innovative Optical Health Sciences, Volume. 5, Issue 2, 1250010(2012)

COLLAGEN AS IN VIVO QUANTITATIVE FLUORESCENT BIOMARKERS OF ABNORMAL TISSUE CHANGES

O. D. SMIRNOVA1、*, D. A. ROGATKIN2, and K. S. LITVINOVA2
Author Affiliations
  • 1Moscow Regional Research and Clinical Institute “MONIKI " Named after M. F. Vladimirskiy Shepkina Str. 61/2, Moscow 129110, Russian Federation
  • 2Moscow Regional Research and Clinical Institute "MONIKI " Named after M. F. Vladimirskiy Shepkina Str. 61/2, Moscow 129110, Russian Federation
  • show less

    Collagen is an endogenous fluorophore that accounts for about 70% of all proteins of human skin, so it can be an optical marker for structural abnormalities in tissues registered by laser fluorescent diagnostics in vivo. Using the examples of such abnormalities as scars, scleroderma and basal cell carcinoma, this study shows the differences between coefficients of fluorescent contrast kf e-T of abnormalities from the ones for healthy tissues at fluorescent excitation wavelength 360-380 nm. It is shown that scars and dysplasia are characterized by reduced values of kf e-T for collagen. Due to high turbidity and phase heterogeneousness as well as variation of parameters of blood microcirculation and concentrations of other related chromophores, there is no mathematical model that precisely calculates the concentration of collagen in tissues only with the use of the value of fluorescent signal intensity. So, probably, the best marker of the pathological process is a comprehensive representation of kf e-T for all endogenous fluorophores, i.e., for all used visible wavelengths. In this case identification of abnormal tissues is quite possible by detecting some deviations of coefficients kf e-T for the optically identical and symmetrical regions of the human body.

    Tools

    Get Citation

    Copy Citation Text

    O. D. SMIRNOVA, D. A. ROGATKIN, K. S. LITVINOVA. COLLAGEN AS IN VIVO QUANTITATIVE FLUORESCENT BIOMARKERS OF ABNORMAL TISSUE CHANGES[J]. Journal of Innovative Optical Health Sciences, 2012, 5(2): 1250010

    Download Citation

    EndNote(RIS)BibTexPlain Text
    Save article for my favorites
    Paper Information

    Received: Apr. 1, 2012

    Accepted: --

    Published Online: Jan. 10, 2019

    The Author Email: SMIRNOVA O. D. (smirnova0ksana@ya.ru)

    DOI:10.1142/s1793545812500101

    Topics